- Home
- AKRO vs MHO Comparison
AKRO vs MHO Comparison
Compare AKRO & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- MHO
- Stock Information
- Founded
- AKRO 2017
- MHO 1976
- Country
- AKRO United States
- MHO United States
- Employees
- AKRO N/A
- MHO N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- MHO Homebuilding
- Sector
- AKRO Health Care
- MHO Consumer Discretionary
- Exchange
- AKRO Nasdaq
- MHO Nasdaq
- Market Cap
- AKRO 3.9B
- MHO 3.9B
- IPO Year
- AKRO 2019
- MHO 1986
- Fundamental
- Price
- AKRO $45.02
- MHO $156.24
- Analyst Decision
- AKRO Strong Buy
- MHO Strong Buy
- Analyst Count
- AKRO 8
- MHO 3
- Target Price
- AKRO $80.38
- MHO $158.67
- AVG Volume (30 Days)
- AKRO 856.3K
- MHO 264.7K
- Earning Date
- AKRO 08-08-2025
- MHO 10-29-2025
- Dividend Yield
- AKRO N/A
- MHO N/A
- EPS Growth
- AKRO N/A
- MHO N/A
- EPS
- AKRO N/A
- MHO 18.23
- Revenue
- AKRO N/A
- MHO $4,486,871,000.00
- Revenue This Year
- AKRO N/A
- MHO N/A
- Revenue Next Year
- AKRO N/A
- MHO $2.33
- P/E Ratio
- AKRO N/A
- MHO $8.14
- Revenue Growth
- AKRO N/A
- MHO 7.46
- 52 Week Low
- AKRO $21.34
- MHO $100.22
- 52 Week High
- AKRO $58.40
- MHO $176.18
- Technical
- Relative Strength Index (RSI)
- AKRO 38.25
- MHO 78.53
- Support Level
- AKRO $43.08
- MHO $143.59
- Resistance Level
- AKRO $46.18
- MHO $147.67
- Average True Range (ATR)
- AKRO 1.62
- MHO 3.63
- MACD
- AKRO -0.30
- MHO 0.41
- Stochastic Oscillator
- AKRO 29.56
- MHO 90.36
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About MHO M/I Homes Inc.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.